Acute glaucoma discovered to be an inflammatory disease

Acute angle closure glaucoma of the right eye (intraocular pressure was 42 in the right eye). Credit: James Heilman, MD/Wikipedia

Researchers at the University of California, San Diego School of Medicine and Sun Yat-sen University in China have shown that acute glaucoma in mice is largely an inflammatory disease and that high pressure in the eye causes vision loss by setting in motion an inflammatory response similar to that evoked by bacterial infections.

The study, published in this week's issue of the Proceedings of the National Academy of Sciences, has immediate clinical relevance in treating the tens of millions of people worldwide from what is known as acute closed-angle .

"Our research is the first to show an inflammatory mechanism by which high ocular pressure causes in acute glaucoma patients," said co-senior author Kang Zhang, MD, PhD and professor of ophthalmology.

The second leading cause of irreversible blindness globally, glaucoma refers to a group of eye diseases associated with elevated broadly classified as either open-angle or closed-angle. Open-angle is sometimes called the silent thief of sight because of its slow, often overlooked progression. By contrast, acute closed-angle glaucoma often is a painful ophthalmologic emergency in which there is a sudden rise in and immediate damage to eyesight.

Less than 10 percent of glaucoma patients in America have the closed-angle form, but in parts of Asia it accounts for almost half of all cases. The higher prevalence of closed-angle glaucoma in Asians and women is believed to be due to a shallower anterior (frontal) eye chamber.

In the study, researchers showed that a rapid, sustained large increase in eye pressure in mice turns on a gene (TLR4) that activates a protein known as caspase-8. This signaling protein in turn triggers the production of inflammatory proteins that normally help mammals fight microbial infections.

"This immune response is a double-edge sword because, while these proteins protect us from infection in a normal situation, they stimulate apoptosis (programmed cell death) in retinal cells in cases of acute glaucoma," said Zhang, who is also a staff physician at the Veterans Affairs San Diego Healthcare System.

To further confirm the mechanism linking high eye pressure to retinal damage, researchers showed that they could slow retinal cell death in mice with acute glaucoma by suppressing either the TLR4 gene or caspace-8 protein.

The latter is particularly significant because caspace-8 inhibitors are currently in clinical trials for treating cancer and stroke. "By injecting these inhibitors into the eyes of acute glaucoma patients, it may be possible to evaluate and bring them vision-sparing treatments more quickly," said co-author Robert N. Weinreb, MD, chairman and Distinguished Professor of Ophthalmology.

More information: Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1402819111

add to favorites email to friend print save as pdf

Related Stories

Open-angle glaucoma up 22 percent in last 10 years

Jan 01, 2013

(HealthDay)—The prevalence of open-angle glaucoma has increased more than 20 percent in the last 10 years and currently affects more than 2.7 million Americans age 40 years and older, according to a report ...

NIH urges dilated eye exams to detect glaucoma

Jan 15, 2013

The National Eye Institute (NEI), a part of the National Institutes of Health, observes Glaucoma Awareness Month each January by encouraging Americans at higher risk for glaucoma to schedule a comprehensive dilated eye exam ...

Researchers identify an early predictor for glaucoma

Jan 02, 2013

A new study finds that certain changes in blood vessels in the eye's retina can be an early warning that a person is at increased risk for glaucoma, an eye disease that slowly robs people of their peripheral vision. Using ...

Glaucoma stent approved

Jun 26, 2012

(HealthDay) -- An ocular stent that's designed to reduce inner-eye pressure among people with mild or moderate open-angle glaucoma has been approved by the U.S. Food and Drug Administration.

Researcher taking the pressure off glaucoma diagnosis

Jun 09, 2014

(Medical Xpress)—Glaucoma represents the second-leading cause of irreversible blindness in the world's aging population, with 400,000 Canadians and 67 million people worldwide suffering from the condition.

Recommended for you

iPads detect early signs of glaucoma in Nepal eye screening

Oct 20, 2014

Using a tablet screening app could prove to be an effective method to aid in the effort to reduce the incidence of avoidable blindness in populations at high-risk for glaucoma with limited access to health care, according ...

Could reading glasses soon be a thing of the past?

Oct 19, 2014

A thin ring inserted into the eye could soon offer a reading glasses-free remedy for presbyopia, the blurriness in near vision experienced by many people over the age of 40, according to a study released today at AAO 2014, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.